Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilektra A Mavroeidi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
PET Clinics|March 30, 2023
Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in SarcomaRainer Hamacher, Helena Lanzafame, Ilektra A Mavroeidi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2024
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical TherapyHelena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P Fendler, Kim M Pabst, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2026
<sup>90</sup>Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort AnalysisHelena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2024
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous TumorRainer Hamacher, Kim M Pabst, Phyllis F Cheung, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational studySabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
PET Clinics|March 30, 2023
Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in SarcomaRainer Hamacher, Helena Lanzafame, Ilektra A Mavroeidi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2024
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical TherapyHelena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P Fendler, Kim M Pabst, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2026
<sup>90</sup>Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort AnalysisHelena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2024
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous TumorRainer Hamacher, Kim M Pabst, Phyllis F Cheung, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational studySabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
Pageof 1